Research Output per year
Fingerprint Dive into the research topics where Paolo Michieli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 39 Similar Profiles
Hepatocyte Growth Factor
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Growth
Medicine & Life Sciences
Oncogenes
Medicine & Life Sciences
Phosphotransferases
Medicine & Life Sciences
p53 Genes
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Antibodies
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1991 2017
- 4441 Citations
- 26 h-Index
- 40 Article
8
Citations
(Scopus)
Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors
Mira, A., Morello, V., Céspedes, M. V., Perera, T., Comoglio, P. M., Mangues, R. & Michieli, P., Jan 1 2017, In : Oncotarget. 8, 24, p. 38193-38213 21 p.Research output: Contribution to journal › Article
Angiogenesis Inhibitors
Hepatocyte Growth Factor
Colorectal Neoplasms
Glucose
SCID Mice
6
Citations
(Scopus)
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy
Godar, M., Morello, V., Sadi, A., Hultberg, A., De Jonge, N., Basilico, C., Hanssens, V., Saunders, M., Lambrecht, B. N., El Khattabi, M., De Haard, H., Michieli, P. & Blanchetot, C., Aug 22 2016, In : Scientific Reports. 6, 31621.Research output: Contribution to journal › Article
Anti-Idiotypic Antibodies
Antibodies
Bispecific Antibodies
Epitopes
Single-Domain Antibodies
7
Citations
(Scopus)
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody
Cignetto, S., Modica, C., Chiriaco, C., Fontani, L., Milla, P., Michieli, P., Comoglio, P. M. & Vigna, E., Jun 1 2016, In : Molecular Oncology. 10, 6, p. 938-948 11 p.Research output: Contribution to journal › Article
Half-Life
Antibodies
Neoplasms
Molecular Weight
Immunoglobulin Fab Fragments
13
Citations
(Scopus)
Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling
Hultberg, A., Morello, V., Huyghe, L., De Jonge, N., Blanchetot, C., Hanssens, V., De Boeck, G., Silence, K., Festjens, E., Heukers, R., Roux, B., Lamballe, F., Ginestier, C., Charafe-Jauffret, E., Maina, F., Brouckaert, P., Saunders, M., Thibault, A., Dreier, T., De Haard, H. & 1 others, , Aug 15 2015, In : Cancer Research. 75, 16, p. 3373-3383 11 p.Research output: Contribution to journal › Article
Neoplasm Antibodies
Hepatocyte Growth Factor
Antibodies
Neoplasms
Therapeutics
47
Citations
(Scopus)
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer
VanSchaeybroeck, S., Kalimutho, M., Dunne, P. D., Carson, R., Allen, W., Jithesh, P. V., Redmond, K. L., Sasazuki, T., Shirasawa, S., Blayney, J., Michieli, P., Fenning, C., Lenz, H. J., Lawler, M., Longley, D. B. & Johnston, P. G., Jun 26 2014, In : Cell Reports. 7, 6, p. 1940-1955 16 p.Research output: Contribution to journal › Article
Mitogen-Activated Protein Kinase Kinases
Colorectal Neoplasms
Chemical activation
Metalloproteases
Systems Biology